未登录

Y

Yoon-Jae Kim

Pukyong National University

H指数:10

被引数:280

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer

HSP90抑制剂HVH-2930对曲妥珠单抗耐药的HER2-positive乳腺癌表现出有效的疗效

IF13.3

2024-01-013

OAAI

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-11-044

OAAI

A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis

一种靶向肿瘤干细胞并抑制TNBC转移的基于氯硝柳胺的双作用前药

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2023-05-1517

OAAI

Optimization of green LED light intensity for accelerating wound healing in olive flounder Paralichthys olivaceus (Temminck et Schlegel)

IF3.9

2023-05-014

PRE

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase

Ebastine通过靶向粘着斑激酶损害三阴性乳腺癌的转移扩散

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2023-04-254

OAAI

A novel C-terminal of HSP90 inhibitor NCT-547 eliminates cancer stem-like subpopulation in triple-negative breast cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Anti-metastatic potential of pitavastatin in triple-negative breast cancer via targeting breast cancer stem-like properties and STAT3 signaling

CANCER RESEARCH

IF16.6

2023-04-041

PRE

UCP2 inhibitor eradicates cancer stem-like population in trastuzumab-resistant HER2-positive breast cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Doxazosin exerts anti-metastatic potential in triple-negative breast cancer via impairment of cancer stem-like features

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Ebastine targets cancer stem cell-like properties and metastasis in triple-negative breast cancer by binding focal adhesion kinase

CANCER RESEARCH

IF16.6

2023-04-040

PRE

β-Escin eradicates cancer stem-like population in HER2-positive breast cancer with trastuzumab resistance

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Cutting Off H+ Leaks on the Inner Mitochondrial Membrane: A Proton Modulation Approach to Selectively Eradicate Cancer Stem Cells

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2023-02-068

PRE

A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis

IF12.9

2022-10-0119

PRE

β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features

CANCER CELL INTERNATIONAL

IF6

2022-09-2010

OAAI

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response

IF7.3

2022-05-0220

OAAI

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

CELL DEATH DISCOVERY

IF7

2021-11-1318

OAAI

Flubendazole targets STAT3 signaling and distant metasis in triple-negative breast cancer

CANCER RESEARCH

IF16.6

2019-07-010

PRE

An anthelmintic drug, flubendazole, exerts antitumor effects in triple-negative breast cancer via targeting cancer stem-like properties

CANCER RESEARCH

IF16.6

2019-07-011

PRE

Disulfiram targets both proliferating cancer cells and cancer stem-like population in ER-positive breast cancer

CANCER RESEARCH

IF16.6

2019-07-011

PRE

Disulfiram overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2/Akt signaling in HER2-positive breast cancer

CANCER RESEARCH

IF16.6

2018-07-010

PRE